Stock Price Bolstered Mid-Session: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)

Modesto Morganelli
Октября 13, 2017

Its down 0.11, from 0.74 in 2017Q1. It turned negative, as 20 investors sold Infinity Pharmaceuticals Inc. shares while 23 reduced holdings. 15 funds opened positions while 12 raised stakes. Amer Gp Inc Inc holds 0.01% or 40,000 shares in its portfolio. California Public Employees Retirement holds 88,100 shares.

Infinity Pharmaceuticals, Inc.in recent headlines. (NASDAQ:INFI) has "Market Perform" rating given on Tuesday, June 14 by JMP Securities. The stock of Infinity Pharmaceuticals Inc. (NASDAQ:INFI). Federated Invsts Incorporated Pa accumulated 3,876 shares or 0% of the stock. Goldman Sachs Grp owns 246,234 shares. Ameriprise Financial reported 82,720 shares. State Street Corp invested in 367,176 shares.

Infinity Pharmaceuticals, Inc.'s stock has a beta of 2.68 so it is more volatile than the market overall which by definition has a beta of 1. (NASDAQ:INFI) for 353,891 shares. Blackrock owns 913,460 shares. Manufacturers Life Insur Communication The holds 0% in Infinity Pharmaceuticals Inc. (NASDAQ:INFI) for 90,720 shares.

05/08/2015 - Infinity Pharmaceuticals, Inc. had its "neutral" rating reiterated by analysts at Nomura. (NASDAQ:INFI) is a huge mover today!

About 770,935 shares traded. Infinity Pharmaceuti (NASDAQ:INFI) has a Return on Assets (ROA) of -59.2. It has underperformed by 77.66% the S&P500.

ILLEGAL ACTIVITY NOTICE: "Infinity Pharmaceuticals, Inc". (NASDAQ:INFI) to report earnings on November, 8. (NYSE:AMC) earnings have risen with a quarterly rate of 5.1% over the last 5 years. The other 0, though not evenly; between analysts who think you should buy Infinity Pharmaceuticals, Inc. versus those who think you should sell it.

06/15/2016 - Infinity Pharmaceuticals, Inc. was downgraded to "market perform" by analysts at William Blair. The rating was downgraded by Wedbush on Tuesday, March 22 to "Underperform". Highbridge Capital Management LLC bought a new position in shares of Infinity Pharmaceuticals in the 1st quarter worth approximately $106,000. As per Wednesday, June 15, the company rating was downgraded by Jefferies. (NASDAQ:INFI). Aperio Gru Ltd Liability has invested 0% in Infinity Pharmaceuticals Inc.

09/03/2014 - Infinity Pharmaceuticals, Inc. had its "positive" rating reiterated by analysts at Roth Capital. (NASDAQ:INFI) also leans strongly towards the neutral end of the spectrum.

On October 12 the company was set at "Outperform" by Wells Fargo a boost from the previous " rating.

More news for Infinity Pharmaceuticals Inc.

(NASDAQ:INFI) is also considered overbought with an RSI (14) of 87.23.

Infinity Pharmaceuticals, Inc.is a biopharmaceutical company. The company shares sank -45.3% from their peak of $74.92 and now has a $650.76 million market value of equity. The Company is engaged in the discovery, development and delivery of medicines to treat diseases. It now has negative earnings. The Firm develops small molecule drugs that target disease pathways for potential applications in oncology.

Altre relazioni

Discuti questo articolo

Segui i nostri GIORNALE

ULTIME NOTIZIE

ALTRE NOTIZIE